COVID-19-positive cases (n = 22) | COVID-19-negative, ORV-positive controls (n = 22) | COVID-19-negative, ORV-negative controls (n = 22) | Overall (N = 66) | |
---|---|---|---|---|
Age (years)† | 45.0 [20.0, 66.0] | 37.5 [18.0, 72.0] | 44.5 [21.0, 64.0] | 44.0 [18.0, 72.0] |
Sex (biological) | ||||
Male | 11 (50.0%) | 11 (50.0%) | 11 (50.0%) | 33 (50.0%) |
Female | 10 (45.5%) | 10 (45.5%) | 10 (45.5%) | 30 (45.5%) |
Prefer not to say | 1 (4.5%) | 1 (4.5%) | 1 (4.5%) | 3 (4.5%) |
Hispanic ethnicity | ||||
No | 19 (86.4%) | 19 (86.4%) | 16 (72.7%) | 54 (81.8%) |
Yes | 2 (9.1%) | 2 (9.1%) | 5 (22.7%) | 9 (13.6%) |
Prefer not to say | 1 (4.5%) | 1 (4.5%) | 1 (4.5%) | 3 (4.5%) |
Race | ||||
American Indian or Alaska Native | 1 (4.5%) | 1 (4.5%) | 2 (9.1%) | 4 (6.1%) |
Asian | 0 (0.0%) | 1 (4.5%) | 2 (9.1%) | 3 (4.5%) |
Black or African American | 10 (45.5%) | 9 (40.9%) | 7 (31.8%) | 26 (39.4%) |
Native Hawaiian or other Pacific Islander | 1 (4.5%) | 1 (4.5%) | 2 (9.1%) | 4 (6.1%) |
White | 4 (18.2%) | 4 (18.2%) | 6 (27.3%) | 14 (21.2%) |
Multiracial | 2 (9.1%) | 2 (9.1%) | 0 (0.0%) | 4 (6.1%) |
Other | 2 (9.1%) | 0 (0.0%) | 0 (0.0%) | 2 (3.0%) |
Prefer not to say | 2 (9.1%) | 4 (18.2%) | 3 (13.6%) | 9 (13.6%) |
Language | ||||
English | 19 (86.4%) | 22 (100.0%) | 21 (95.5%) | 62 (93.9%) |
Spanish | 2 (9.1%) | 0 (0.0%) | 1 (4.5%) | 3 (4.5%) |
Tigrinya | 1 (4.5%) | 0 (0.0%) | 0 (0.0%) | 1 (1.5%) |
Education | ||||
Less than high school graduate | 4 (18.2%) | 2 (9.1%) | 2 (9.1%) | 8 (12.1%) |
Graduated high school/obtained GED | 7 (31.8%) | 6 (27.3%) | 6 (27.3%) | 19 (28.8%) |
Some college‡ | 3 (13.6%) | 6 (27.3%) | 8 (36.4%) | 17 (25.8%) |
Bachelor's or advanced degree | 1 (4.5%) | 7 (31.8%) | 6 (27.2%) | 14 (21.2%) |
Prefer not to say | 1 (4.5%) | 1 (4.5%) | 0 (0.0%) | 2 (3.0%) |
Missing | 6 (27.3%) | 0 (0.0%) | 0 (0.0%) | 6 (9.1%) |
Employed | ||||
No | 13 (59.1%) | 14 (63.6%) | 9 (40.9%) | 36 (54.5%) |
Yes | 3 (13.6%) | 8 (36.4%) | 13 (59.1%) | 24 (36.4%) |
Missing | 6 (27.3%) | 0 (0.0%) | 0 (0.0%) | 6 (9.1%) |
Income | ||||
≤ $25,000 | 10 (45.5%) | 10 (45.5%) | 15 (68.2%) | 35 (53.0%) |
> $25,000 | 1 (4.5%) | 6 (27.3%) | 5 (22.7%) | 12 (18.2%) |
Don't know or prefer not to say | 5 (22.7%) | 6 (27.3%) | 2 (9.1%) | 13 (19.7%) |
Missing | 6 (27.3%) | 0 (0.0%) | 0 (0.0%) | 6 (9.1%) |
Insurance | ||||
Private | 0 (0.0%) | 6 (27.3%) | 5 (22.7%) | 11 (16.7%) |
Government | 15 (68.2%) | 12 (54.5%) | 12 (54.5%) | 39 (59.1%) |
None | 0 (0.0%) | 3 (13.6%) | 4 (18.2%) | 7 (10.6%) |
Prefer not to say | 1 (4.5%) | 1 (4.5%) | 1 (4.5%) | 3 (4.5%) |
Missing | 6 (27.3%) | 0 (0.0%) | 0 (0.0%) | 6 (9.1%) |
Duration of homelessness | ||||
6 months or less | 2 (9.1%) | 5 (22.7%) | 5 (22.7%) | 12 (18.2%) |
7–12 months | 1 (4.5%) | 3 (13.6%) | 4 (18.2%) | 8 (12.1%) |
13–24 months | 4 (18.2%) | 3 (13.6%) | 0 (0.0%) | 7 (10.6%) |
Over 24 months (2 years) | 8 (36.4%) | 4 (18.2%) | 5 (22.7%) | 17 (25.8%) |
Prefer Not to Say | 1 (4.5%) | 1 (4.5%) | 1 (4.5%) | 3 (4.5%) |
Missing | 6 (27.3%) | 6 (27.3%) | 7 (31.8%) | 19 (28.8%) |
Shelter Type | ||||
Mixed gender, ≥ 18 years | 11 (50.0%) | 9 (40.9%) | 7 (31.8%) | 27 (40.9%) |
Mixed gender, 18—25 years | 0 (0.0%) | 2 (9.1%) | 1 (4.5%) | 3 (4.5%) |
Female, ≥ 18 years | 0 (0.0%) | 2 (9.1%) | 2 (9.1%) | 4 (6.1%) |
Male, ≥ 18 years | 2 (9.1%) | 2 (9.1%) | 2 (9.1%) | 6 (9.1%) |
Male, ≥ 50 years | 1 (4.5%) | 0 (0.0%) | 3 (13.6%) | 4 (6.1%) |
Mixed gender, all ages | 8 (36.4%) | 7 (31.8%) | 7 (31.8%) | 22 (33.3%) |
Any comorbidities§ | 6 (27.3%) | 7 (31.8%) | 6 (27.3%) | 19 (28.8%) |
Smoking status | ||||
None | 12 (54.5%) | 11 (50.0%) | 15 (68.2%) | 38 (57.6%) |
Tobacco products | 9 (40.9%) | 10 (45.5%) | 6 (27.3%) | 25 (37.9%) |
Prefer not to say | 1 (4.5%) | 1 (4.5%) | 1 (4.5%) | 3 (4.5%) |
Any symptoms at enrollment | 5 (22.7%) | 2 (9.1%) | 4 (18.2%) | 11 (16.7%) |
Follow-up time since enrollment (days)† | 72.0 [35.0, 183.0] | 180 [96.0, 223.0] | 123 [96.0, 188.0] | 126 [35.0, 223.0] |
Follow-up season‖ | ||||
Fall | 1 (4.55%) | 16 (72.7%) | 13 (59.1%) | 30 (45.5%) |
Spring | 3 (13.6%) | 0 (0.0%) | 0 (0.0%) | 3 (4.5%) |
Winter | 18 (81.8%) | 0 (0.0%) | 0 (0.0%) | 18 (27.3%) |
Summer | 0 (0.0%) | 6 (27.3%) | 9 (40.9%) | 15 (22.7%) |
Any symptoms at follow-upa | 9 (40.9%) | 5 (22.7%) | 7 (31.8%) | 21 (31.8%) |